- There has been an improvement in gross profit margin.
- Vaccines in both Poultry and animal division registered a 20% growth on QoQ basis
- Health product side the company registered growth 48% on QoQ basis
Geographical coverage
- Domestic sales grew by 43% on qoq.
- Export reduced considerably by 51% on QoQ.
- The demand of the products in India has shot up tremendously & comoany made sure that the demand in the country is met.
Current situation: Bird Flu
- The company's sales has not been impacted by bird flu and the company has been able to register a good growth.
- Company is looking to acquire other company and Hester is near to being close for choosing atleast one option for manufacturing and one for distribution side on international basis
- If these acquisition are successful then company would achieve a high expansion plan
Hester, Nepal
- Covid lockdown made things difficult to execute the current year plans.
Hester, Tanzania
- Things have taken a longer time, there has been a little bit of turbulence due to high transport cost but the investment is small so its not substantial yet.
Debt
- Debt ratio is reducing and the company has now a good cash balance.
- Consolidated debt: Rs.114 crores.
- Debt would be used in future Capex.
Working capital
- There has been a sizeable improvement in working capital cycle even better than the precovid days.
- Going forward, with the demand of the product, the company would be able to maintain such working capital.
Capex
- Company is in the stage of finalization of the plan.
- Pending Capex in tanzania is less than Rs. 5crores and there is no overrun in the Hester Africa project. Production will start from May 2021.
"Asset now created on animal health side would churn out more higher turnover compared to putting as much money in vaccine plant."
Marketing expansion
- Next round of hiring marketing people would from first quarter of next financial year.
- Company is creating a balance between getting more sales and improving the efficiency per sales person as far a India is concerned.
- In Africa, company hopes to create the distribution network by mid first quarter next year or towards the end of first quarter.
" The pet market size is very small in india. In USA, there is more sales through pet care market than the organized poultry market."
- Animal health business is a good growing business all across the world.
- Poultry is reasonably consolidated business growing at 8%
- Company sees a metamorphic change in India in terms of cattle business where scattered business would get consolidated in big dairy farms.
- People are getting into organized sheep and goat farming.
- Hester is the first comapny to manifacture the Goatpox vaccine.
- Animal health is going to restructure which is going to give a large business to the company.
β’ β’ β’
Missing some Tweet in this thread? You can try to
force a refresh
β’ Speed of filing products has been increased. Filed 5 new DMFs β 3 in US and 2 in EU
β’ Currently ramping up the facility in VIZAG with strong customer attraction, and will be commercialized as planned in Q3
β’ VIZAG EBIDTA growth guidance changed to 40%+ YoY
β’ Growth Driver: Broad based growth in other products and Vizag.
β’ PLI: Company has filed Mysore for PLI scheme for 1 molecule.
β’ Technology: Company is about to complete its 2 out of 3 technology, which will enhance efficiency for Solara.
Shankara Building Products concall was today at 11:30 AM π
Here are the Key takeaways from the earning call ππ§΅
Business Updates:
β’ Q3 has seen uptick in the demand and co. is at its 80% of the pre-covid sales.
β’ There has been pick up in all the segment.
β’ Affordable Housing Segment has seen growth in the driver of business.
Segments
β’ Retail sector has seen 14% of the revenue growth. Revenue contribution 60%.
β’ Company has decreased the number of stores, as co. believes that they can work more efficiently with less number of stores.
β’ Avg ticket size of the company has been increased. (See image)